NEW YORK, NY / ACCESSWIRE / August 10, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Forescout Technologies, Inc. (NASDAQ: FSCT)
CONTACT JAKUBOWITZ ABOUT FSCT:
Class Period : February 6, 2020 - May 15, 2020
Lead Plaintiff Deadline : August 10, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Forescout was experiencing a significant and disproportionate decline in its financial performance; (2) the foregoing was reasonably likely to have a material negative impact on Forescout's planned acquisition by Advent International Corp.; and (3) as a result of the foregoing, defendants' statements about its business and operations were materially false and misleading at all relevant times.
Endo International Plc (NASDAQ: ENDP)
CONTACT JAKUBOWITZ ABOUT ENDP:
Class Period : August 8, 2017 - June 10, 2020
Lead Plaintiff Deadline : August 18, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Endo's and/or its subsidiaries' contributions to the opioid crisis (including, but not limited to, their opioid products' disproportionately negative impact on New York and the fraud that Defendants perpetrated on the New York insurance market) were larger in scope than the Company had represented; (ii) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (iii) the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Guidewire Software, Inc. (NYSE: GWRE)
CONTACT JAKUBOWITZ ABOUT GWRE:
Class Period : March 6, 2019 - March 4, 2020
Lead Plaintiff Deadline : September 23, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) that the Company's transition to the cloud was not going well; (2) that Guidewire's cloud-based products needed to be improved to meet customer needs and catch up with rival systems; (3) that the Company's failed transition to the cloud was also hurting Guidewire's traditional on-premise business; and (4) as a result, Guidewire's revenue guidance, including guidance principally based on significantly increasing demand for the Company's cloud-based products, was baseless and unattainable.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
1140 Avenue of the Americas
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com: